Physician profile
Gary M Wiltz
NPI 1477596351
$582.89
in general payments reported to CMS, 2019-2025
12 companies · $92.47 in 2025
The $92.47 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.18 · 2020: $65.08 · 2021: $272 · 2022: $35.49 · 2023: $35.79 · 2024: $63.11 · 2025: $92.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $116.83 | 2020-2021 | |
| Exact Sciences Corporation | $113.03 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $90.49 | 2021 | |
| Vanda Pharmaceuticals INC. | $60.78 | 2021 | |
| Pfizer INC. | $56.39 | 2021-2025 | |
| Axsome Therapeutics, INC. | $35.00 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $30.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.25 | 2022 | |
| Allergan, INC. | $19.18 | 2019 | |
| Vifor Pharma, INC. | $16.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.73 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wiltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.